We utilized immunohistochemistry to examine KDM5B protein expression in two PCa cohorts that contained benign prostate tissue, primary adenocarcinoma, metastatic and neuroendocrine prostate specimens. This evidence concerns the gene KDM5B and posterior cortical atrophy.